Article
Personalized Stem Cell Therapy to Correct Corneal Defects Due to a Unique Homozygous-Heterozygous Mosaicism of Ectrodactyly-Ectodermal Dysplasia-Clefting Syndrome.
Stem cells translational medicine - 1 Aug 2016
Barbaro Vanessa, Nasti Annamaria Assunta, Raffa Paolo, Migliorati Angelo, Nespeca Patrizia, Ferrari Stefano, Palumbo Elisa, Bertolin Marina, Breda Claudia, Miceli Francesco, Russo Antonella, Caenazzo Luciana, Ponzin Diego, Palù Giorgio, Parolin Cristina, Di Iorio Enzo
Abstract excerpt
UNLABELLED: : Ectrodactyly-ectodermal dysplasia-clefting (EEC) syndrome is a rare autosomal dominant disease caused by mutations in the p63 gene. To date, approximately 40 different p63 mutations have been identified, all heterozygous. No definitive treatments are available to counteract and resolve the progressive corneal degeneration due to a premature aging of limbal epithelial stem cells. Here, we describe a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
